Stock screenerAll disclosures →
EDGAR →
ELVN
Conviction 100HealthcareScan · Thu, Jun 25, 2026ELVN$49.09+2.76%
ResistanceSupportVol 14Insider sell6
3
3
3
Vol MA14 2.76M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price49.09
Change+2.76%
Gap+0.16%
Rel volume2.40×
Avg volume2.2M
Avg $ vol94.84M
SMA 2040.95
SMA 5041.98
SMA 20028.78
Price vs 50+16.93%
Price vs 200+70.55%
MA stackbullish
50/200 cross—
Supertrendup · 39.44
RSI (14)66
MACD hist1.14
MACD crossbull · 8d
Stoch %K / %D91 / 92
ADX (14)31
+DI / −DI31 / 10
RSI divergence—
MACD divergence—
ATR %+6.34%
ADR %7.20%
52w high49.09
52w low15.14
From 52w high+0.00%
Above 52w low+224.24%
New 52w highYes
SqueezeOff
Bollinger width48.33%
%B0.91
Donchian pos91.44%
Donchian high50.56
Donchian low33.45
AVWAP (52w high)49.16
vs AVWAP high-0.13%
AVWAP (52w low)35.68
vs AVWAP low+37.59%
OBV trendUp
Chaikin MF (20)-0.07
Today vs 20d2.40×
Avg vol (14d)2.76M
Avg vol (20d)2.2M
Avg $ vol (20d)94.84M
Market cap2.99B
RS 3m (vs SPY)+41.10%
RS 6m (vs SPY)+175.43%
RS line new highNo
Trend template8/8
Technical rank94.9
1 week+9.43%
1 month+15.42%
3 months+38.16%
6 months+173.79%
1 year+131.99%
YTD+215.89%
P/E-28.83
P/B6.59
P/S—
P/FCF-42.43
EPS-1.83
Div yield—
ROE-22.87%
ROA-22.31%
Debt/Eq—
Current40.32
EV/EBITDA-23.94
Gross margin—
Net margin—
Rev growth—
EPS growth-16.48%
Price target59.56
Target upside21.33%
Analyst ratingBuy
Institutional93.99%
Ent. value2.86B
Revenue—
Net income-23.63M
Gross profit—
Free cash flow-70.46M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out60.9M
Employees61
ListedFri, Feb 24, 2023
Free float45.39M
Float %76.5%
Short interest5.21M
Days to cover8.7d
Short volume45.4%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.38 vs −$0.44
Last surprise+13.6% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank94.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance46.25
Support36.02
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ELVN
No recent disclosed trades by Congress in ELVN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ELVN · 2 buys · 8 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-06-17 | Exercise | 5K | $12K | 2026-06-17 | 2026-06-22 |
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-06-17 | Sell | 1.27K | $54K | 2026-06-17 | 2026-06-22 |
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-06-17 | Sell | 2.6K | $114K | 2026-06-17 | 2026-06-22 |
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-06-17 | Sell | 1.13K | $51K | 2026-06-17 | 2026-06-22 |
Collins Helen Louise CHIEF MEDICAL OFFICER · Stock Option (right to buy) · 2026-06-17 | Exercise | 5K | — | 2026-06-17 | 2026-06-22 |
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-17 | Exercise | 6.02K | $15K | 2026-06-17 | 2026-06-22 |
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-17 | Sell | 1.38K | $59K | 2026-06-17 | 2026-06-22 |
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-17 | Sell | 3.4K | $149K | 2026-06-17 | 2026-06-22 |
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-17 | Sell | 1.24K | $55K | 2026-06-17 | 2026-06-22 |
Hohl Benjamin CHIEF FINANCIAL OFFICER · Stock Option (right to buy) · 2026-06-17 | Exercise | 6.02K | — | 2026-06-17 | 2026-06-22 |
SEC filings
EDGAR filings in ELVN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.